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Resveratrol (3,5,40-trihydroxy-trans stilbene) is commonly recognized by its antioxidant properties.
Despite its beneficial qualities, the toxic effects of this natural compound are still unknown. Since mito-
chondria are essential to support the energy-dependent regulation of several cell functions, the objective
of this study was to evaluate resveratrol effects on rat brain and liver mitochondrial fractions from male
and females regarding oxidative stress and bioenergetics. No basal differences were observed between
mitochondrial fractions from males and females, except in liver mitochondria, the generation of H2O2
by the respiratory chain is lower for female preparations. Resveratrol inhibited lipid peroxidation in prep-
arations from both genders and organs. Furthermore, brain mitochondria in both gender groups appeared
susceptible to resveratrol as seen by a decrease in state 3 respiration and alterations in mitochondrial
membrane potential fluctuations during ADP phosphorylation. As opposed, liver mitochondria were less
affected by resveratrol. Our data also demonstrates that resveratrol inhibits complex I activity in all
mitochondrial preparations. The results suggest that brain mitochondria appear to be more susceptible
to resveratrol effects, and gender appears to play a minor role. It remains to be determined if resveratrol
effects on brain mitochondria contribute to deterioration of mitochondrial function or instead to mediate
hormesis-mediated events.
 2012 Elsevier Ltd. All rights reserved.1. Introduction
The redox active polyphenol compound resveratrol (3,5,40-tri-
hydroxy-trans stilbene) was firstly identified in roots from white
hellebore (Veratrum album) and later in roots from Japanese knot-
weed (Polygonum cuspidatum) (Nonomura et al., 1963). Resveratrol
is also found in grapes (Vitis vinifera), grape juice, wine berries
(Vaccinium macropon) and peanuts (Arachis hypogaea) (Fremont,
2000; Pervaiz, 2003). Resveratrol has been shown to trigger several
physiological effects in laboratory animals, resulting in cancer pre-
vention, microvascular and neuroprotection as well as antidiabeticll rights reserved.
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+351 239 855 760; fax: +351effects (Baur and Sinclair, 2006). Resveratrol is one of the main
components of red wine, the consumption of which is associated
with a lower incidence of heart failure in France (Richard, 1987).
The protective effects are associated with antioxidant proprieties
that were confirmed in the heart in different models (Gresele
et al., 2011), including lipopolysaccharide (LPS)-induced oxidative
stress (Sebai et al., 2011) and doxorubicin (DOX)-induced cardio-
toxicity (Xu et al., 2012).
Resveratrol crosses the blood–brain barrier (BBB) (Wang et al.,
2002), demonstrating neuroprotective effects in several disorders
such as cerebral ischemia and Alzheimer’s disease (Baur and
Sinclair, 2006). Resveratrol also increases spatial memory perfor-
mances in the circular platform tasks in primates (Dal-Pan et al.,
2011), thus demonstrating cognitive and neuroprotective effects
(Agarwal and Baur, 2011; Huber and Superti-Furga, 2011). Fukiu
et al. showed that resveratrol induces the expression of mitochon-
drial superoxide dismutase (SOD2) and as a consequence reduces
mitochondrial oxidative stress and damage in neurons (Fukui
et al., 2010).
Specifically in the liver, resveratrol up-regulates the expression
of glucogenic genes by attenuating insulin signaling and by deacet-
ylating FOXO1 (Park et al., 2010). Resveratrol also decreases
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the survival of mice during cholestatic liver injury (Chan et al.,
2011). Although the protective effects of resveratrol on heart
mitochondria have been described (Gutierrez-Perez et al., 2011),
mitochondrial-specific studies are lacking in liver and brain
mitochondria.
Mitochondria are the cell powerhouses due to the synthesis of
ATP by oxidative phosphorylation (Pereira et al., 2009a). Mitochon-
dria are also a major endogenous source of reactive oxygen species,
either under normal (Rigoulet et al., 2011) or pathological
(Puente-Maestu et al., 2012; Reale et al., 2012) conditions.
Macromolecular oxidative damage in mitochondria induces a de-
cline in the efficiency of oxidative phosphorylation, and result in
the induction of the mitochondrial permeability transition and in
the release of pro-apototic factors that trigger apoptosis (Pereira
et al., 2009a). With this in mind, several effects of resveratrol on
cells may be derived from direct or indirect mitochondrial effects.
To support the evidence that resveratrol presents direct effects on
mitochondria, we have isolated fractions from rat liver and brain
and investigated whether resveratrol alters mitochondrial bioener-
getics and prevents induced oxidative damage. A second important
question was whether resveratrol-induced mitochondrial effects
are gender-dependent. To answer this latter question, mitochon-
drial fractions were isolated from female and male rats. Isolated
mitochondrial fractions are a recognized model to measure com-
pound toxicity (Pereira et al., 2009b). Nevertheless, the large
majority of experiments is performed with mitochondrial fractions
from male animals. Differences between mitochondrial fractions
from male and female animal models may influence the final out-
come of chemical-biological interactions at the mitochondrial le-
vel. The concentrations used in this study are within the
concentration range used by others (Annabi et al., 2012; He
et al., 2012; Price et al., 2012; Valdecantos et al., 2010).
2. Material and methods
2.1. Chemicals
All chemicals used in this work were purchased from Sigma Aldrich Co (St.
Louis, MO), unless specified. Resveratrol was prepared in DMSO, the final volume
used was lower than 0.1% (v/v); aqueous solutions were prepared in ultrapure
water (Milli-Q Biocel A10 with pre-treatment via Elix 5, Millipore, Billerica, MA,
USA). Non-aqueous solutions were prepared in ethanol. In this case, the final vol-
ume used was always lower than 0.1% (v/v).
2.2. Animals
Male and female Wistar rats (8–12 weeks) from our animal colony (Center for
Neuroscience and Cell Biology, University of Coimbra) were housed in type III-H
cages (Tecniplast, Italy) with irradiated corn cob grit bedding (Scobis Due, Mucedo-
la, Italy), following environmental requirements with ad libitum acess to food
(4RF21, Mucedola, Italy) and water and maintained at constant temperature
(22 C) and humidity with a 12 h light/dark cycle. Animal handling and sacrifice fol-
lowed the procedures approved by the Federation of European Laboratory Animal
Science Associations (FELASA). Animal handlers and the authors ACM and VAS are
credited by FELASA (category C) for animal experimentation.
2.3. Mitochondria preparation
The livers were quickly removed and mitochondria were isolated by conven-
tional methods (Moreno et al., 2007). Briefly, liver mitochondria were isolated using
an homogenization media composed of 250 mM sucrose, 5 mM Hepes, 0.5 mM
EGTA and 0.1% defatted bovine serum albumin containing medium (pH = 7.2).
The mitochondrial pellet was washed twice and suspended in washing buffer
(250 mM sucrose, 10 mM HEPES, pH = 7.4). Brain mitochondria were isolated by a
previously published method (Rosenthal et al., 1987), using 0.02% digitonin to re-
lease mitochondria from the synaptosomal fraction. The whole brain except for
the cerebellum was immediately removed, washed and homogenized at 4 C in
10 mL of isolation medium (225 mM mannitol, 75 mM sucrose, 5 mM Hepes,
1 mM EGTA, 1 mg/ml defatted BSA, pH 7.4) containing 5 mg of the bacterial prote-
ase (Subtilisin A, type VIII from Bacillus licheniformis, Sigma). Single brain homoge-
nates were brought to 30 ml and then centrifuged at 746g (Sorvall RC-5BRefrigerated Superspeed Centrifuge) for 5 min. The pellet was resuspended in
10 ml of the isolation medium containing 0.02% digitonin and centrifuged at
11,950g for 10 min. The pellet was then resuspended in 10 ml of resuspension med-
ium (225 mM mannitol, 75 mM sucrose, 5 mM Hepes, pH 7.4) and centrifuged at
11,950 xg for 5 min. Finally, the mitochondrial pellet was ressuspended in about
200 ll of resuspension medium. Mitochondrial protein was determined by the Biu-
ret method calibrated with bovine serum albumin (Gornall et al., 1949).2.4. Lipid peroxidation
Lipid peroxidation was evaluated following oxygen consumption using a Clark-
type electrode in a glass chamber with magnetic stirring, at 30. Mitochondria
(1 mg and 0.8 mg for liver and brain, respectively) were pre-incubated for 3 min
with resveratrol in 1 ml of medium containing 175 mM KCl and 10 mM Tris–Cl
(pH = 7.4), supplemented with 2 lM rotenone (in the presence or absence of resve-
ratrol) to inhibit mitochondrial respiration induced by endogenous substrates.
Membrane lipid peroxidation was initiated by adding 1 mM adenosine diphosphate
(ADP)/0.1 mM Fe2+ as oxidizing pair. Controls (basal levels) in absence of ADP/Fe2+,
were performed under the same conditions. Lipid peroxidation was also evaluated
by thiobarbituric acid reactive species (TBARS) generation according to a modified
procedure (Santos et al., 2001). Briefly, aliquots of mitochondrial suspension were
obtained 10 min after the addition of ADP/Fe2+ and added to 0.5 ml of ice-cold
40% trichloroacetic acid. Then, 2 ml of aqueous thiobarbituric acid (0.67%) contain-
ing 0.001% of 2.6-di-tert-butyl-p-cresol was added to the samples. The mixtures
were heated at 90 for 10 min and the supernatant fractions were collected and
the absorbance read at 530 nm in a Spectronic 21 spectrophotometer (Bausch &
Lomb, NY, USA). The amount of TBARS formed was calculated using a molar extinc-
tion coefficient of 1.56  105 mol1 cm1 and expressed as nmol TBARS/mg pro-
tein (Moreira et al., 2011; Santos et al., 2001).2.5. Hydrogen peroxide generation
Hydrogen peroxide (H2O2) generation was measured fluorimetrically using a
modification of a previously described method (Barja, 2002). Briefly, mitochondria
were incubated with 1.5 mM of phosphate buffer, pH 7.4, containing 0.1 mM EGTA,
145 mM KCl, 30 mM Hepes, and 0.1 mM homovalinic acid and 6U/ml horseradish
peroxidase. Resveratrol was incubated for 3 mins with mitochondrial fractions.
The reactions were initiated by adding 5 mM/2.5 mM glutamate/malate. The fluo-
rescence was measured with 312 nm as excitation wavelength and 420 nm as emis-
sion wavelength in Victor X3 Multilabel reader (Perkin Elmer, Waltham, USA).
Hydrogen peroxide generation was calculated using a standard curve of H2O2,
freshly prepared. The standards and the samples were incubated under the same
conditions.2.6. Mitochondrial respiration
Oxygen consumption was measured polarographically with a Clark-type Oxy-
gen electrode connected to a recorder in a thermostated water-jacketed closed
chamber with magnetic stirring. The reactions were performed at 30 C in 1 ml of
standard respiratory medium with 1 mg of liver mitochondria or 0.5 mg of brain
mitochondria. For liver mitochondria, the reaction medium used was composed
by 130 mM sucrose, 50 mM KCl, 2.5 mM KH2PO4, 5 mM Hepes and 2 mM MgCl2;
for brain mitochondria, the reaction medium was composed of 100 mM sucrose,
100 mM KCl, 2 mM KH2PO4, 5 mM Hepes and 0.01 mM EGTA (pH 7.4). Respiration
was initiated with 5 mM glutamate/2.5 mM malate and state 3 started by adding
ADP (150 nmol/mg protein for brain mitochondria and 125 nmol/mg protein for li-
ver mitochondria). Respiration rates were obtained assuming an oxygen concentra-
tion of 236 nmol O2/ml in the experimental medium at 30 C (Rasmussen and
Rasmussen, 2003). The respiratory state 2 (oxygen consumption before ADP addi-
tion – v2), state 3 (oxygen consumption in the presence of ADP – v3), state 4 (oxy-
gen consumption after ADP phosphorylation – v4) and respiratory control ratio
(RCR = state 3/state 4) were obtained according to Chance and Williams (1956).
The ADP/O ratio is expressed as the ratio between the amount of ADP added and
the oxygen consumed during v3. Resveratrol was pre-incubated with mitochondrial
suspension for 3 min before ADP addition.
In order to determine the possible site of resveratrol interaction, mitochondrial
fractions were frozen/thawed three times and oxygen consumption was assessed
by using a Clark oxygen type electrode in 1 ml of reaction medium composed by
130 mM sucrose, 50 mM KCl, 2.5 mM KH2PO4, 5 mM Hepes and 2 mM MgCl2 (liver
mitochondria) or 100 mM sucrose, 100 mM KCl, 2 mM KH2PO4, 5 mM Hepes and
0.01 mM EGTA (brain mitochondria). One or 0.8 mg mitochondrial protein was used
for liver and brain preparations, respectively. Mitochondrial lysates were incubated
with resveratrol for three minutes. The direct effects on complex I-sustained respi-
ration were measured in the presence of 1 mM of NADH, while direct effects on
complex II-sustained respiration were assessed in the presence of 5 mM of succi-
nate and 2 lM rotenone.
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The mitochondrial transmembrane electric potential (Dwm) was estimated by
the transmembrane distribution of the lipophilic cation tetraphenylphosphonium
(TPP+) by using a selective electrode prepared as previously described following
the Kamo instructions (Kamo et al., 1979), using an Ag/AgCl2—saturated electrode
as reference. TPP+ uptake was measured from the decrease in TPP+ concentration
in the medium as sensed by the electrode (Oliveira et al., 2004). Mitochondria (1
or 0.5 mg/ml) were incubated in the standard reaction medium supplemented with
3 lMTPP+ and energized by the addition of 5 mM glutamate/2.5 mMmalate. After a
steady-state distribution of TPP+ was reached (after about 1 min of recording), ADP
was added and Dwm fluctuations recorded. Resveratrol was pre-incubated with
mitochondrial suspension for 3 min before ADP addition.2.8. Complex I activity
The maximal activity of mitochondrial complex I was assessed in disrupted
mitochondrial preparations after three cycles of freezing/thawing. One hundred
and ninety ll of reaction medium (25 mM KH2PO4, pH = 7.5, 5 mM MgCl2,
300 lM KCN), supplemented with 4 lM antimycin A, 3 mg/ml BSA, 60 lM coen-
zyme Q1, 160 lM DCPIP and 10 lg/ml of brain or liver mitochondria were trans-
ferred to a 96-well plate. One micromolar of complex I inhibitor rotenone, 25 lM
resveratrol or 5 ll EtOH (vehicle) were added to the respective wells. Enzymatic
activity of brain and liver preparations was measured through a decrease in absor-
bance of DCPIP after the addition of 100 lM fresh-prepared NADH in a Victor X3
plate reader (Perkin Elmer, Waltham, USA) at 600 nm. Enzyme activity was calcu-Fig. 1. Effects of resveratrol on membrane lipid peroxidation of rat and liver mitochondri
evaluated following oxygen consumption resulting from membrane peroxidation (A
mitochondrial preparations from brain and liver of male and female rats. The data in pa
significance: ###p < 0.001 compared with the respective basal levels, ⁄p < 0.05, ⁄⁄⁄p < 0.0lated by using the slope achieved during the linear phase (15 cycles). Specific com-
plex I activity was calculated through the difference with the basal activity in the
presence of rotenone.
2.9. Statistical analysis
The results are representative of at least three different preparations from indi-
vidual animals as described in the legends of the figures. Values are presented as
mean ± SEM and were compared by two-way ANOVA followed by Bonferroni
post-test or t-student test. A value of p < 0.05 was considered significant.3. Results
3.1. Resveratrol decreases lipid peroxidation in brain and liver
mitochondria
The effects of resveratrol on oxidative damage were assessed by
mitochondria membrane peroxidation induced by the pro-oxidant
pair ADP/Fe2+ (Fig. 1). This effect was evaluated by measuring
oxygen consumption (Fig. 1A) and TBARS formation (Fig. 1B). In
the absence of resveratrol and after the addition of ADP/Fe2+, it is
possible to observe a two-phase kinetic in oxygen consumption:
an initial phase with a slower oxygen consumption that is followeda induced by the pro-oxidant pair ADP/Fe2. ADP/Fe2+-induced lipid peroxidation was
) and TBARS colorimetric assay (B). Panel A represents a typical recording of
nel B represent the mean ± SEM of four to six independent experiments. Statistical
01 compared with the mitochondria in the presence of the pair ADP/Fe2+.
Fig. 2. Effect of resveratrol on mitochondrial hydrogen peroxide (H2O2) production.
The production of hydrogen peroxide by the mitochondrial respiratory chain was
evaluated as described in the materials and methods section. Mitochondrial
fractions from brain (0.5 mg) and liver (1 mg) of male and female Wistar–Han rats
were incubated with standard respiratory medium in the presence or absence of
resveratrol. Basal levels of H2O2 production were determined in the absence of
mitochondrial substrates. Glutamate/malate (5 mM/2.5 mM) was used as substrate.
Rotenone (1.0 lM) and antimycin A (0.5 lM) were used to increase H2O2 produc-
tion. Data represent mean ± SEM from independent experiments. Statistical signif-
icance: ⁄p < 0.05, when compared with respective gender preparation, #p < 0.05,
##p < 0.01 when compared with respective control, ap < 0.05, aaap < 0.001 when
compared with the absence of inhibitors.
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initial phase is likely due to the time needed to generate the perfer-
ryl ion complex that has been suggested to be the responsible for
the initiation of lipid peroxidation. The quickly oxygen consump-
tion is due to the oxidation of the polyunsaturated fatty acid acyl
chain of the phospholipidic membrane by ROS, leading to the prop-
agation of lipid peroxidation (Fernandes et al., 2006). As observed
in Fig. 1A, in both genders and both organs, the pro-oxidant pair
ADP/Fe2+ induced an increase in oxygen consumption that is de-
creased in the presence of resveratrol to nearly no-oxidant basal
levels. The data are in accordance with the results obtained by
measuring TBARS formation. Pre-incubation with the highest con-
centration of resveratrol 25 lM) lead to a decrease in TBARS pro-
duction in both organs and genders (brain mitochondria, males:
12.5 ± 2.5 vs. 3.0 ± 0.7, brain mitochondria females: 10.5 ± 1.1 vs.
4.4 ± 1.6; male mitochondria, liver: 9.7 ± 0.7 vs. 0.6 ± 0.2, female
mitochondria, liver: 11.4 ± 0.9 to 0.6 ± 0.2 nmol TBARS/mg protein,
without vs. with resveratrol) (Fig. 1B). For the lowest concentration
used (10 lM), resveratrol had no effect on brain mitochondrial
fractions, as opposed to liver mitochondria, where protection
against lipid peroxidation-induced TBARS generation was observed
for both genders.3.2. Resveratrol increases the mitochondrial H2O2 production in liver
Liver and brain mitochondria from male and female rats were
incubated with resveratrol in order to investigate the effects of
the compound on hydrogen peroxide generation by the respiratory
chain.
In both genders, treatment of mitochondria with rotenone (a
complex I inhibitor) or antimycin A (a complex III inhibitor) max-
imally induces H2O2 generation, as expected (Chen et al., 2003;
Leloup et al., 2006) (Fig. 2). When analyzing H2O2 production in
untreated mitochondria (Fig. 2), liver mitochondria from female
rats have generally a lower basal H2O2 generation when compared
with preparations from male rats. The same effect was not ob-
served in brain mitochondrial fractions. When resveratrol was
added to the different experimental groups, some interesting ef-
fects were observed. When added to liver mitochondria, resvera-
trol increased H2O2 generation when glutamate-malate was used
alone (Fig. 2B), in both preparations from male and female rats.
In brain mitochondrial fractions (male only), resveratrol amplified
the effect of antimycin A in increased H2O2 generation (Fig. 2A).
We also compared directly liver and brain mitochondrial frac-
tions from both genders in terms of basal activity of glutathione
peroxidase (GPx) and glutathione content. We have measured that
in general, liver mitochondrial have increased GPx, with fractions
from females having the highest activity (345.80 ± 46.01 to
216.40 ± 17.71 U/mg protein of male fractions, Fig. S1). No differ-
ences were observed in terms of GSH, GSSG or GSH/GSSG ratio (Ta-
ble S1).
3.3. Resveratrol decreases state 3 respiration in brain mitochondria
The next question in this work led us to investigate direct
effects of resveratrol on liver and brain mitochondrial respiration
for both genders. In the absence of resveratrol, no differences
between genders were observed. The addition of resveratrol
(10, 25 lM) to freshly isolated brain mitochondria induced con-
sumption decrease of state 3 respiration from 44.0 ± 1.8 to
33.5 ± 3.5 nmol O2/mg protein for males and from 44.1 ± 3.0 to
32.8 ± 3.7 nmol O2/mg protein for preparations from female ani-
mals (Fig 3A). The alterations in respiration state 3 in brain mito-
chondria were not reflected in the RCR (Fig. 3C), may be due to
the fact that the oxygen consumption has also has a tendency to
be decreased by resveratrol during state 4 (p = 0.0591, Fig. 3B).
No alterations were observed for liver mitochondria (Fig. 3). The
ADP/O, a measure of the efficiency of oxidative phosphorylation,
was not altered after resveratrol incubation for any of the groups
studied (Fig. 3D).
3.4. Mitochondrial membrane potential during ADP phosphorylation is
affected by resveratrol
Gender did not influence the different end-points regarding
mitochondrial transmembrane electric potential (Fig. 4). Resvera-
trol did not affect the maximum transmembrane electric potential
developed by mitochondria for both genders and organs (Fig. 4A).
However, the depolarization induced by ADP is decreased by resve-
ratrol at 25 lM in brain and liver mitochondria (Fig. 4B). In brain
mitochondria, the decrease was from 15.3 ± 1.0 to 10.3 ± 2.7 (prep-
arations from males) and 14.2 ± 1.0 to 9.3 ± 1.5 (preparations from
females), numbers in (mV). When using liver mitochondria, the
decrease was from 20.4 ± 2.1 to 15.7 ± 0.8 (preparations from
male) and from 19.5 ± 0.4 to 16.2 ± 0.4 (preparations from fe-
males), results in (mV). Although there is not a statistical differ-
ence, the lag phase showed a tendency to be increased in brain
mitochondria from male rats when incubated with 25 lM resvera-
trol (p = 0.0591).
Fig. 3. Resveratrol effects on mitochondrial respiration: (A) mitochondrial state 3 respiration; (B) mitochondrial state 4 respiration; (C) respiratory control ratio (RCR);
(D) ADP/O. Brain (0.5 mg) and liver (1 mg) mitochondria were incubated with 10 or 25 lM of resveratrol for 3 min in 1 mL of respiration media supplemented with 5 mM
glutamate and 2.5 ml malate. ADP (75 nmol for brain mitochondria and 125 nmol for liver mitochondria) was added to induce state 3 respiration. The RCR was calculated as
the ratio between state 3 and state 4 respiration. The ADP/O was calculated as the number of nmol ADP phosphorylated per natom oxygen consumed during state 3. Data
represent mean ± SEM from four to six independent experiments. Statistical significance: ⁄p < 0.05, when compared with the respective control.
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Fig. 4. Resveratrol effects on mitochondrial DW fluctuations: (A) Maximum mitochondrial membrane potential developed (DW) after mitochondrial energization;
(B) Depolarization induced by ADP addition; (C) Time elapsed during complete ADP phosphorylation (lag phase). Brain (0.5 mg) and liver (1 mg) mitochondria were incubated
with 10 or 25 lM of resveratrol for 3 min in 1 ml of standard respiratory medium. Mitochondria were energized with 5 mM glutamate and 2.5 ml malate and the
phosphorylation cycle was initiated with ADP (75 nmol for brain mitochondria and 125 nmol for liver mitochondria). Data represent mean ± SEM from four to six
independent experiments. Statistical significance ⁄p < 0.05 and ⁄⁄p < 0.01 when compared with the respective control.
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By using disrupted mitochondrial membranes and specific sub-
strates, one can evaluate distinct sites of drug-induced toxicity.
Resveratrol decreases oxygen consumption in frozen/thawed mito-
chondrial preparations from liver and brain when using NADH as
substrate (Fig 5A and E). Preparations from brains of male rats
showed a resveratrol-induced decrease in oxygen consumption
from 56.3 ± 4.4 to 48.81 ± 3.6 nmol O2/ mg protein/ min; while a
decrease from 44.8 ± 5.2 to 36.2 ± 3.4 nmol O2/mg protein/ min
was observed in brain preparations from female rats. When inves-
tigating liver mitochondrial preparations, resveratrol also inhibited
complex I-sustained respiration in male (24.7 ± 1.7 to 21.0 ±
1.4 nmol O2 consumed/mg/min) and female rats (19.9 ± 0.9 to
16.4 ± 0.9 nmol O2 consumed/mg/min). Interestingly, NADH-sustained oxygen consumption in both tissues was higher in
preparations from males when compared with preparations from
female animals. The same experiments were performed by using
the complex II substrate succinate (in the presence of complex I
inhibitor rotenone). In this case, resveratrol had no effect on succi-
nate-induced mitochondrial respiration.
In parallel, the maximum activity of complex I was investigated
using a colorimetric method. For both organs and genders, resvera-
trol decreased complex I specific activity. In brain mitochondria, a
decrease of 22% and 11% was observed in preparations from male
and female preparations, respectively. A higher magnitude effect
was observed in liver mitochondria, where the activity in the pres-
ence of resveratrol decreased 73% for male preparations and prac-
tically 100% in the case of preparations from female rats. The
maximal activity of complex I did not differ between genders.
Fig. 5. Resveratrol inhibition of mitochondrial complex I. Resveratrol effects on mitochondrial oxygen consumption in disrupted mitochondrial membranes was measured in
a Clark-type electrode during 4 min after NADH (complex I, A, B, E, F) or succinate plus rotenone addition (complex II, C, D, G, H) in preparations frommale and female Wistar
rats. Data represent mean ± SEM from five to eight independent experiments. Statistical significance: for male populations ⁄p < 0.05, ⁄⁄p < 0.01, ⁄⁄⁄p < 0.001 when compared
with the respective control and for female preparations #p < 0.05 when compared with respective control, $p < 0.05, compared with male.
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Table 1
Effect of resveratrol on brain and liver mitochondrial respiratory complex I maximum
activity. Activity expressed as nmol DCPIP/min/mg protein.
Male Female
Ctrl Resv Ctrl Resv
Brain 135.7 ± 16.82 106.6 ± 13.05⁄ 112.4 ± 4.724 99.61 ± 4.3⁄
Liver 49.74 ± 12.14 13.65 ± 13.27⁄ 52.12 ± 4.97 0.00 ± 12.47⁄
Data are the mean ± SEM of four independent experiment. Statistical significance:
⁄p < 0.05 when compared with the respective control.
A.C. Moreira et al. / Food and Chemical Toxicology 53 (2013) 18–26 254. Discussion
There is a growing amount of studies focusing on natural com-
pounds and their possible benefits in terms of human health.
Although the antioxidant, anti-inflammatory and anti-tumoral ef-
fects of resveratrol (Delmas et al., 2006; Pervaiz and Holme,
2009) have been widely described, the cellular toxicity was not
yet completely evaluated, especially regarding mitochondrial
bioenergetics.
Following previous works showing protective effects of resvera-
trol on brain and liver (Morin et al., 2003; Park et al., 2010; Pervaiz
and Holme, 2009), the present work investigates its toxicity on iso-
lated brain and liver mitochondria at concentrations that act to de-
crease oxidative stress. The use of brain and liver mitochondria
was due to the fact that resveratrol is able to cross the BBB (Wang
et al., 2002) and it is highly metabolized in the liver (Walle, 2011),
respectively. The present work highlights the relevance of using
mitochondrial-isolated fractions from male and female rats, which
is very rare in the literature. Although we did not observe basal dif-
ferences in mitochondrial preparations from both genders in most
of the parameters investigated, except when measuring maximal
respiration due to freezing/thawing cycles, it is known that estro-
gens have protective effects, enhancing antioxidant defenses and
decreasing mitochondrial dysfunction (Borras et al., 2007; Eskes
and Haanen, 2007; Vina et al., 2011). For instance, in liver mito-
chondrial the H2O2 levels are lower in females than in males
(Fig. 2). This can be due to the activity of GPx, which is augmented
in liver preparations from females (Fig. S1), although no differences
were measured in brain or in reduced and oxidized GSH (Table S1).
Female rats have better mitochondrial capacity showing less oxi-
dative stress generation based in estrogen levels (Borras et al.,
2003; Guevara et al., 2011). Sex hormones have neuroprotective ef-
fects, which have also been shown to increase mitochondrial effi-
ciency (Nilsen and Brinton, 2004). Besides, the differences in
gender, we aimed to discuss the different effects of resveratrol
and to observe its effects on mitochondrial function for concentra-
tions known to act as antioxidant. Our results confirm previous
studies (Aftab et al., 2010; Ghanim et al., 2011; Kelsey et al.,
2010; Toklu et al., 2010) regarding the antioxidant proprieties of
resveratrol (Fig. 1). Our data shows that resveratrol indeed acts
as an antioxidant by the measurement of TBARS and by following
oxygen consumption during lipid peroxidation. In both cases
(Fig. 1), resveratrol was able to decrease lipid peroxidation, disre-
garding the gender. Resveratrol increases H2O2 generation in both
male and female liver mitochondria in the presence of the sub-
strate (glutamate-malate) alone. The effect is not observed with
brain mitochondria (Fig. 2), except when mitochondria are incu-
bated with complex III inhibitor, antimycin A (Fig. 2A). The resve-
ratrol effects on liver mitochondria in terms of H2O2 generation can
be explained by a direct action on complex I, or instead, as
previously reported, by modulation of mitochondrial Manganese-
superoxide dismutase (Robb et al., 2008), increasing the flux of
hydrogen peroxide production.
Concerning effects of resveratrol on mitochondrial bioenerget-
ics, Zini et al., showed that resveratrol inhibits brain mitochondrial
respiratory chain at the complexes I–III span (Zini et al., 1999). In
this work, the enzymatic activity of ubiquinol cytochrome c reduc-
tase in the presence of resveratrol was decreased by 20% (Zini et al.,
1999). The authors suggest that resveratrol can preserve mitochon-
drial functions by three different mechanisms: antioxidant-
mediated effect, complex III direct effect and membrane stabilizing
effects (Zini et al., 2002). A decrease of state 3 in brain mitochon-
dria of female and male rats was observed in the presence of res-
veratrol (Fig. 3). Since the maximal transmembrane electric
potential developed was not affected by resveratrol (Fig. 4), thissuggests that the respiratory chain was not largely inhibited,
although we cannot exclude that increased H2O2 generation results
from inhibition of complex I and/or III. Instead, the results from
both respiration (Fig. 3) and transmembrane electric potential
(Fig. 4) suggest an effect on the phosphorylative system, including
in the adenine nucleotide transporter, the phosphate transporter,
or even with the ATP synthase (Gledhill and Walker, 2005). Inter-
estingly, inhibition of state 3 respiration was not observed in liver
mitochondria. Although the reason for this difference is still un-
clear, it may have to do with differential accumulation of resvera-
trol in mitochondrial membranes from both gender groups or with
the different number of target complex subunits present in both
preparations.
We further described that resveratrol inhibits mitochondrial
respiration induced by NADH, but not succinate, in freeze/thawed
preparations, which indirectly allows to study the maximal respi-
ration rate (Fig. 5). In accordance, resveratrol also reduced complex
I specific activity as followed by the reduction of DCPIP (Table 1).
This data demonstrates that resveratrol acts as a complex I inhib-
itor in mitochondrial preparations from both organs and genders.
Interestingly, although resveratrol induced a larger inhibition of
complex I activity in liver freeze/thawed preparations, the same
type of effect was not visible when using intact mitochondria
(Fig. 3). This may imply that the site of resveratrol inhibition on
complex I faces the matrix side, being more accessible when mito-
chondrial membranes are disrupted to perform specific assays
with NADH. The data also supplies evidence that resveratrol may
also target complex I besides the already described complex III
(Zini et al., 1999), thus contributing to increase the generation of
hydrogen peroxide by the respiratory chain (Fig. 2).
The results may also suggest that increased generation of H2O2
in liver and, under some conditions, in brain mitochondria by res-
veratrol can act to stimulate several signaling pathways, including
those related with antioxidant defenses. The effects of resveratrol
in the metabolism of different organs and gender-mediated effects
should be explored in further detail to determine potential toxic ef-
fects and mechanisms by which resveratrol is described to cell
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